# National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

> **NCT02192619** · — · UNKNOWN · sponsor: **Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH** · enrollment: 500 (estimated)

## Conditions studied

- Newly-diagnosed APL (de Novo or Therapy-related)
- Relapsed APL

## Interventions

- **OTHER:** observational

## Key facts

- **NCT ID:** NCT02192619
- **Lead sponsor:** Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-07
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2024-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02192619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02192619, "National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02192619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*